Choose languange: English|Japanese
denizli escort sex izle porno bodrum escort

BioTie’s Selincro to market

March 1, 2013

BioTie’s Selincro to market

Selincro, the drug originally developed by BioTie Therapies for the reduction of alcohol consumption in adult patients with alcohol dependence has received marketing authorization to all 27 European Union member states. BioTie’s partner Lundbeck expects to launch Selincro in its first markets in mid-2013. Congratulations BioTie!

Read BioTie’s Stock Exchange release

Leave a Comment

(required)

(required)

(required)


Stay connected with us in your favorite flavor!